Guided Therapeutics (GTHP) Preferred Shares (2013 - 2026)

Guided Therapeutics has disclosed Preferred Shares across 12 years of filings, most recently posting $226000.0 for Q2 2026.

• In Q2 2026, Preferred Shares fell 72.9% year-over-year to $226000.0; the TTM figure through Jun 2026 stood at $226000.0 (down 72.9% YoY), while the FY2025 annual figure was $817000.0, down 2.04% from the prior year.
• Preferred Shares came in at $226000.0 for Q2 2026 at Guided Therapeutics, roughly flat from $226000.0 in the prior quarter.
• In the past five years, Preferred Shares ranged from a high of $3.0 million in Q1 2022 to a low of $226000.0 in Q1 2026.
• Average Preferred Shares over 5 years is $985833.3, with a median of $838000.0 recorded in 2023.
• Year-over-year, Preferred Shares jumped 80.78% in 2022 and plunged 72.9% in 2026.
• Over 5 years, Preferred Shares stood at $880000.0 in 2022, then fell by 4.77% to $838000.0 in 2023, then slipped by 0.48% to $834000.0 in 2024, then slipped by 2.04% to $817000.0 in 2025, then sank by 72.34% to $226000.0 in 2026.
• Per Business Quant data, the three most recent Preferred Shares figures were $226000.0 in Q2 2026, $226000.0 in Q1 2026, and $817000.0 in Q4 2025.